- Home
- CCO vs REPL Comparison
CCO vs REPL Comparison
Compare CCO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- REPL
- Stock Information
- Founded
- CCO 1995
- REPL 2015
- Country
- CCO United States
- REPL United States
- Employees
- CCO N/A
- REPL N/A
- Industry
- CCO Advertising
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- CCO Consumer Discretionary
- REPL Health Care
- Exchange
- CCO Nasdaq
- REPL Nasdaq
- Market Cap
- CCO 586.5M
- REPL 547.0M
- IPO Year
- CCO 2005
- REPL 2018
- Fundamental
- Price
- CCO $1.28
- REPL $5.67
- Analyst Decision
- CCO Hold
- REPL Buy
- Analyst Count
- CCO 5
- REPL 10
- Target Price
- CCO $1.88
- REPL $8.25
- AVG Volume (30 Days)
- CCO 4.0M
- REPL 17.2M
- Earning Date
- CCO 08-05-2025
- REPL 08-07-2025
- Dividend Yield
- CCO N/A
- REPL N/A
- EPS Growth
- CCO N/A
- REPL N/A
- EPS
- CCO 0.04
- REPL N/A
- Revenue
- CCO $1,538,895,000.00
- REPL N/A
- Revenue This Year
- CCO $5.23
- REPL N/A
- Revenue Next Year
- CCO $3.41
- REPL $194.05
- P/E Ratio
- CCO $29.10
- REPL N/A
- Revenue Growth
- CCO 31.61
- REPL N/A
- 52 Week Low
- CCO $0.81
- REPL $2.68
- 52 Week High
- CCO $1.77
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- CCO 62.18
- REPL 45.73
- Support Level
- CCO $1.02
- REPL $5.08
- Resistance Level
- CCO $1.22
- REPL $5.84
- Average True Range (ATR)
- CCO 0.07
- REPL 0.46
- MACD
- CCO 0.02
- REPL 0.17
- Stochastic Oscillator
- CCO 98.08
- REPL 62.11
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.